Followers | 28 |
Posts | 1197 |
Boards Moderated | 0 |
Alias Born | 05/14/2014 |
Tuesday, October 04, 2016 12:16:18 PM
That's what I'm trying to figure out. He's a contract executive, and I would have originally guessed the board just wanted an interim chief to keep the company afloat a little longer. However, I think the addition of Mr. Yung was more strategic than that. Here's some of his publicly available professional experience:
National CRM & Sales Force Effectiveness Manager
- GlaxoSmithKline
Regional Sales Manager - GI and Anti-Infectives
- AstraZeneca
Regional Sales Manager
- Device Technologies
Head, Learning & Organizational Development
- Device Technologies
Coaching, Professional Development and Knowledge Acquisition
- Private
Digging further, a lot of these positions focus on sales and marketing assessment and development. The other day I expressed my concern that even with NV receiving the license for testing, Abattis might have a tough time building influence and making the necessary sales to drive revenue. Michael Yung could be the desperately needed tie to bring this all together.
Any thoughts or other pertinent information I may be missing out there?
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM